Roundup non-Hodgkins Lymphoma Lawsuit Ends in $1.25M Verdict Against Bayer

The plaintiff indicated he developed non-Hodgkin's lymphoma from Roundup, after using the weed killer as part of a neighborhood restoration project.

A St. Louis jury has ordered Bayer to pay $1.25 million in a Roundup lawsuit brought by a man who says the weed killer caused him to develop non-Hodgkin’s lymphoma.

The lawsuit was filed by John Durnell, and the verdict was handed down Friday in the Missouri 22nd Judicial Circuit Court, breaking a nine-case winning streak by manufacturers of the herbicide in recent state-court trials.

Over the past eight years, Bayer and its Monsanto subsidiary have faced more than 120,000 Roundup lawsuits, each raising similar allegations that former users developed non-Hodgkin’s lymphoma after exposure to the weedkiller, either when using the product in an agricultural setting or around the homes.

After getting hit with a series of massive verdicts in 2018 and 2019, Bayer has agreed to pay billions in Roundup settlements to resolve individual injury lawsuits. However, the deals still left tens of thousands of claims unresolved, as many users rejected the settlement offers, and new lawsuits continue to be filed as former users develop non-Hodgkins lymphoma.

ROUNDUP LAWSUITS

Were you or a loved one exposed to RoundUp?

Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin's Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated.

Learn More See If You Qualify For Compensation

According to Durnell’s original lawsuit, he began using Roundup in 1996 in St. Louis as part of the Soulard Restoration Project and was diagnosed with non-Hodgkin’s lymphoma several years later.

Last week, the jury awarded $1.25 million in compensatory damages, representing the first state court verdict returned against Bayer and Monsanto outside of California.

The litigation began to emerge in 2015, when the World Health Organization’s International Agency for Research on Cancer (IARC) decided to classify glyphosate in Roundup as a probable cancer-causing agent.

While the outcome of Durnell’s lawsuit  will not have any binding impact on other claims, it was being closely watched to help gauge how juries in Missouri may respond to certain evidence and testimony that is likely to be repeated throughout the litigation. Most of the U.S. case are currently pending in Missouri state court, where Monsanto’s U.S. headquarters are located and it remains a major employer.

In addition to the state court litigation, hundreds of claims are currently centralized in the federal court system before U.S. District Judge Vince Chhabria in the Northern District of California, where several large waves of claims are being prepared for remand to different federal district court for trial.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits
Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits (Posted yesterday)

A federal judge has agreed to divide lawsuits over gastroparesis injuries linked to drugs like Ozempic and Mounjaro into multiple phases, examining how the condition is diagnosed and whether plaintiffs' claims are preempted by federal laws.

Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn
Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn (Posted 2 days ago)

Lawsuit alleges that Abbott Laboratories failed to provide families and the medical community with adequate warnings about the risks associated with it’s cow’s milk-based Similac formula, which a now adult woman indicates has left her with life-long NEC injuries.

Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects
Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects (Posted 3 days ago)

Six breast cancer patients have asked a federal judge for permission to amend a complaint filed in March 2024, which describes problems linked to the device and painful side effects experienced when the tissue marker migrated out of position or shattered inside their bodies.